Literature DB >> 30404109

Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Marco A Alba1, J Charles Jennette1, Ronald J Falk2,3.   

Abstract

Antineutrophil cytoplasmic antibodies (ANCAs) are autoantibodies specific for antigens located in the cytoplasmic granules of neutrophils and lysosomes of monocytes. ANCAs are associated with a spectrum of necrotizing vasculitis that includes granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Pulmonary vasculitis and related extravascular inflammation and fibrosis are frequent components of ANCA vasculitis. In this review, we detail the factors that have been associated with the origin of the ANCA autoimmune response and summarize the most relevant clinical observations, in vitro evidence, and animal studies strongly indicating the pathogenic potential of ANCA. In addition, we describe the putative sequence of pathogenic mechanisms driven by ANCA-induced activation of neutrophils that result in small vessel necrotizing vasculitis and extravascular granulomatous necrotizing inflammation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30404109      PMCID: PMC6343662          DOI: 10.1055/s-0038-1673386

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  131 in total

1.  ANCA patients have T cells responsive to complementary PR-3 antigen.

Authors:  Jiajin Yang; David J Bautz; Sofia Lionaki; Susan L Hogan; Hyunsook Chin; Roland M Tisch; John L Schmitz; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

2.  Germinal centre-like structures in Wegener's granuloma: the morphological basis for autoimmunity?

Authors:  A Mueller; K Holl-Ulrich; P Lamprecht; W L Gross
Journal:  Rheumatology (Oxford)       Date:  2008-05-31       Impact factor: 7.580

3.  Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil.

Authors:  S S Dhillon; D Singh; N Doe; A M Qadri; S Ricciardi; M I Schwarz
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

4.  Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Milorad Pavlovic; Zoran Dimcic; Branislava Ivanovic; Milos Nikolic
Journal:  Clin Rheumatol       Date:  2010-03-20       Impact factor: 2.980

Review 5.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

6.  Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis.

Authors:  Francisco Silva; Ulrich Specks; Sanjeev Sethi; Maria Valentina Irazabal; Fernando C Fervenza
Journal:  Am J Kidney Dis       Date:  2009-04-23       Impact factor: 8.860

7.  Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis.

Authors:  Philippe Guilpain; Amélie Servettaz; Claire Goulvestre; Sandrine Barrieu; Didier Borderie; Christiane Chéreau; Niloufar Kavian; Christian Pagnoux; Loïc Guillevin; Bernard Weill; Luc Mouthon; Frédéric Batteux
Journal:  Arthritis Rheum       Date:  2007-07

8.  Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.

Authors:  F Moosig; E Csernok; G Wang; W L Gross
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

9.  Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Authors:  C A Stegeman; J W Tervaert; P E de Jong; C G Kallenberg
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

10.  Idiopathic lung fibrosis and anti myeloperoxidase glomerulonephritis: the tree that hides the forest.

Authors:  Marc Pineton de Chambrun; Hilario Nunes; Isabelle Brochériou; Alexandre Hertig
Journal:  BMC Pulm Med       Date:  2015-10-26       Impact factor: 3.317

View more
  12 in total

Review 1.  Childhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?

Authors:  Renato Ferrandiz-Espadin; Manuel Ferrandiz-Zavaler
Journal:  Curr Rheumatol Rep       Date:  2019-08-29       Impact factor: 4.592

Review 2.  Mechanisms of vascular damage in ANCA vasculitis.

Authors:  David Massicotte-Azarniouch; Carolina A Herrera; J Charles Jennette; Ronald J Falk; Meghan E Free
Journal:  Semin Immunopathol       Date:  2022-03-07       Impact factor: 11.759

Review 3.  Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype.

Authors:  Maricruz Domínguez-Quintana; Marco A Alba; Andrea Hinojosa-Azaola
Journal:  Rheumatol Int       Date:  2021-08-12       Impact factor: 2.631

4.  Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage and Glomerulonephritis Complicating Acute Influenza Infection.

Authors:  Leanne Dada; Loutfi Succari; Amy Y Vittor; William L Clapp; Haoyang Zhuang; Sami K Saikaly; Jena Auerbach; Shuhong Han; Borna Mehrad; Westley H Reeves
Journal:  J Clin Rheumatol       Date:  2021-12-01       Impact factor: 3.517

5.  Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis.

Authors:  Yosuke Kameoka; Fukuko Kishi; Minako Koura; Yoshio Yamakawa; Rora Nagasawa; Fuyu Ito; Junichiro Matsuda; Osamu Suzuki; Toshinori Nakayama; Kazuo Suzuki
Journal:  Drug Des Devel Ther       Date:  2019-02-05       Impact factor: 4.162

Review 6.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

7.  Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease.

Authors:  Christian W Cox; Brian J Bartholmai; Misbah Baqir; Jennifer R Geske; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

Review 8.  ANCA Status or Clinical Phenotype - What Counts More?

Authors:  Martin Windpessl; Erica L Bettac; Philipp Gauckler; Jae Il Shin; Duvuru Geetha; Andreas Kronbichler
Journal:  Curr Rheumatol Rep       Date:  2021-04-28       Impact factor: 4.592

9.  Possible Association Between COVID-19 Infection and De Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Nima Madanchi; Facundo E Stingo; Kennerly C Patrick; Selvaraj Muthusamy; Neha Gupta; Yahya Imran Fatani; Nehal Shah
Journal:  Cureus       Date:  2021-12-10

10.  False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis.

Authors:  Argyrios Tzouvelekis; Theodoros Karampitsakos; Anastasia Krompa; Evangelos Markozannes; Demosthenes Bouros
Journal:  Front Med (Lausanne)       Date:  2020-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.